<SEC-DOCUMENT>0001013762-24-001424.txt : 20240726
<SEC-HEADER>0001013762-24-001424.hdr.sgml : 20240726
<ACCEPTANCE-DATETIME>20240726132107
ACCESSION NUMBER:		0001013762-24-001424
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240726
DATE AS OF CHANGE:		20240726

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			60 DEGREES PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001946563
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				452406880
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280796
		FILM NUMBER:		241145308

	BUSINESS ADDRESS:	
		STREET 1:		1025 CONNECTICUT AVENUE NW
		STREET 2:		SUITE 1000
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20036
		BUSINESS PHONE:		202-327-5422

	MAIL ADDRESS:	
		STREET 1:		1025 CONNECTICUT AVENUE NW
		STREET 2:		SUITE 1000
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20036
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>ea0210113011-424b5_60degrees.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><B><BR>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><B>Filed Pursuant to Rule 424(b)(5)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white"><B>Registration&nbsp;No.&nbsp;333-<FONT STYLE="background-color: white">280796</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>PROSPECTUS SUPPLEMENT No.&nbsp;3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>(To the Prospectus and Prospectus Supplement
dated July 12, 2024)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Up to $2,190,416</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="A logo with blue text&#10;&#10;Description automatically generated" STYLE="height: 146px; width: 367px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>60 Degrees Pharmaceuticals, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We have entered into an At
the Market Issuance Sales Agreement (the &ldquo;Sales Agreement&rdquo;) with WallachBeth Capital LLC (&ldquo;WallachBeth&rdquo;) relating
to shares of our common stock offered by this prospectus supplement, the accompanying amendment no. 2 (the &ldquo;Amendment No. 2 to Prospectus
Supplement&rdquo;) and the accompanying amendment no. 1 to the prospectus supplement dated as of July 22, 2024 (&ldquo;Amendment No. 1
to Prospectus Supplement&rdquo;), the prospectus supplement dated as of July 12, 2024 (&ldquo;Prospectus Supplement&rdquo;) and the prospectus
dated as of July 12, 2024 (&ldquo;Base Prospectus&rdquo;). In accordance with the terms of the Sales Agreement, we may offer and sell
shares of our common stock, par value $0.0001 per share, from time to time through WallachBeth acting as our agent (the &ldquo;ATM Offering&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Our common stock is listed
on The Nasdaq Capital Market under the symbol &ldquo;SXTP.&rdquo; On July 25, 2024, the last reported sale price of our common stock on
The Nasdaq Capital Market was $0.188 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We are filing this prospectus
supplement to supplement and amend, as of July 26, 2024, the accompanying Amendment No. 2 to Prospectus Supplement, Amendment No. 1 to
Prospectus Supplement, Prospectus Supplement and Base Prospectus to increase the maximum aggregate gross sales price of our common stock
that may be offered, issued and sold under the Sales Agreement from and after the date hereof to $2,190,416 (the &ldquo;ATM Offering Size
Increase&rdquo;). Under the Prospectus Supplement, we initially registered up to $1,253,603 of our common stock and under the Amendment
No. 1 to Prospectus Supplement, we subsequently registered up to $1,774,640 of our common stock and under Amendment No. 2 to Prospectus
Supplement, we subsequently registered up to $1,890,705 of our common stock for offer and sale pursuant to the Sales Agreement. As of
the date of the filing of this prospectus supplement, we have sold a total of 7,525,879 shares of our common stock that are covered by
Amendment No. 2 to Prospectus Supplement, Amendment No. 1 to Prospectus Supplement and Prospectus Supplement pursuant to the Sales Agreement
for an aggregate gross sales price of $1,890,500.81.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The purpose of this prospectus
supplement is to update the accompanying Amendment No. 2 to Prospectus Supplement, Amendment No. 1 to Prospectus Supplement and the Prospectus
Supplement to reflect the ATM Offering Size Increase. Except as modified by this prospectus supplement, the terms of the ATM Offering
remain unchanged, and the Sales Agreement remains in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate market value of our outstanding common
stock held by non-affiliates is approximately $6,571,249, based on 20,211,995 shares of outstanding common stock, of which 18,721,508
shares are held by non-affiliates, and a share price of $0.351 per share, which was the closing sale price of our common stock as quoted
on The Nasdaq Capital Market on June 7, 2024. During the 12 calendar months prior to and including the date of this prospectus supplement,
we have sold securities with an aggregate market value of $1,890,500.81 pursuant to General Instruction I.B.6 of Form S-3. One-third of
our public float, calculated in accordance with General Instruction I.B.6 of Form S-3, is equal to approximately $299,915 after deducting
the aggregate market value of securities sold pursuant to General Instruction I.B.6 of Form S-3. In no event will we sell securities registered
on the registration statement of which this prospectus supplement forms a part in a public primary offering with a value exceeding more
than one-third of our public float in any 12-month period so long as our public float remains below $75 million pursuant to General Instruction
I.B.6 of Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Our business and an investment in our common stock
involve significant risks. These risks are described under the caption &ldquo;Risk Factors&rdquo; beginning on&nbsp;pages&nbsp;S-22&nbsp;and
18 of the accompanying Prospectus Supplement and Base Prospectus, respectively, and in the documents incorporated by reference into the
accompanying Amendment No. 2 to Prospectus Supplement, Amendment No. 1 to Prospectus Supplement, Prospectus Supplement and Base Prospectus,
as well as the risks and uncertainties described in other documents we file with the Securities and Exchange Commission (&ldquo;SEC&rdquo;).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><B>Neither the SEC nor any
state securities commission has approved of anyone&rsquo;s investment in these securities or determined if this prospectus supplement
or the accompanying Prospectus Supplement or Base Prospectus are truthful or complete. Any representation to the contrary is a criminal
offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>WallachBeth Capital LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>The date of this prospectus
supplement is July 26, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "2 6\# 2(  A$! Q$!_\0
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MY@^)">9\3-5CSC?-&N?3*J*WP]*-234C&M4<(W1[3_PMGP7_ -!?_P @2?\
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M -E%<!X8UZ'0?$,.LWED-0:+<ZQL^W]X?XLX/3FLJ=!*I+2]MBYUFX1Z7.P
M^+<EO_: ?5]A&[&Y0<?]<^OZ5T?P]^*=U?ZE'H?B+;Y\K;(;D+L)?^XX['W]
M>*K_ /"^QWT ?^!7_P!C7F?B3Q!'K'B:?6[2U%BTCK+Y:ONPXQELX'4C-:J$
MJB<9P2\T2YJ#3C*Y] _$+QK_ ,(9I$3P1++?W3%($;[JXZL?89''O7C\?B3X
MD:XDFH6=SJ\T"DDO:Q8C'L !@UW/Q8T#4?$/AW2-8LH'G>WB+311C+;753N
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M<2YYVJ.F<=3]*(J,Z+<G97$W*-717=CW"Q^)/A'4+I;>#6X!*QPHD#1@GZL
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M7L[6L8IIM\][F#\/;?[)\5=/MO,$GDW$L>\#AMJL,_I74_'K_D)Z)_UQE_\
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+?NC\J**I[DH__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
